Photo: ninaraCrescent Island Game Park in Kenya’s Rift Valley.
Could another seemingly obscure mosquito-borne disease that formerly existed mostly in Africa spread around the globe like the Zika virus?
Scientists say climate change increases that risk. With warming temperatures, mosquitoes carrying diseases are more abundant and are spreading to farther regions of the world. For journalists looking for stories about climate change and public health, infectious disease is a rich area for exploration. Continue reading
CDC/ Sarah Bailey Cutchin
As sexually transmitted diseases, like chlamydia, gonorrhea and syphilis, have surged 31 percent over the past five years, states are relying more than ever on disease detectives to halt that spread.
These detectives are called “disease intervention specialists.” They are trained to track down and counsel people who have been diagnosed with STDs and anyone they have had intimate contact with. The aim is to ensure everyone is tested and treated, preventing anyone else from getting the STD. Continue reading
President Trump, along with immigration opponents, repeatedly assert that immigrants are bringing infectious diseases to the U.S., but never provide any data to back up their claims.
That is because virtually every public health expert says there isn’t any evidence that this is the case. Continue reading
A strain of an influenza virus now circulating in China remains a potential pandemic threat while many gaps remain in preparing for such an event, a group of global health experts at the National Academy of Sciences (NAS) warned last month.
The virus spreading in China, called H7N9 (flu virus names reflect their protein makeup) first emerged among poultry workers in 2013 and has sickened 1,567 people and killed 615. Continue reading
Cities provide unique views on the concentrated nature of how policies play out in the everyday lives of their citizens. Attendees at AHCJ’s Urban Health Journalism Workshop in October were treated to an overview of the Big Apple’s public health initiatives and efforts to address disparities, as part of the workshop’s opening session. Continue reading
In early October, the U.S. Food and Drug Administration approved Paratek Pharmaceuticals’ new antibiotic Nuzyra, which kills bacteria associated with skin and lung infections.
The approval was notable because there are so few new antibiotics coming onto the market, , says journalist Maryn McKenna in Wired magazine, largely because most drug companies don’t think antibiotics — which have wiped out the threat of many infectious diseases — to be worth the investment.
The problem is a unique business and policy dilemma for society. Continue reading